Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches

Nanoscale strategies: doxorubicin resistance challenges and enhancing cancer therapy with advanced nanotechnological approaches

Doxorubicin (DOX), an anthracycline, is widely used in cancer treatment by interfering RNA and DNA synthesis. Its broad antitumour spectrum makes it an effective therapy for a wide array of cancers. However, the prevailing drug-resistant cancer has proven to be a significant drawback to the success...

Full description

Saved in:
Bibliographic Details
Main Authors: Lim, Jian Xin, Yong, Yoke Keong, Dewi, Firli Rahmah Primula, Chan, Siok Yee, Lim, Vuanghao
Format: Article
Language:en
Published: Springer 2025
Online Access:http://psasir.upm.edu.my/id/eprint/117151/1/117151.pdf
http://psasir.upm.edu.my/id/eprint/117151/
https://link.springer.com/article/10.1007/s13346-025-01790-3?error=cookies_not_supported&code=314861ea-2c07-4a76-9037-7948f6843992
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://psasir.upm.edu.my/id/eprint/117151/1/117151.pdf
http://psasir.upm.edu.my/id/eprint/117151/
https://link.springer.com/article/10.1007/s13346-025-01790-3?error=cookies_not_supported&code=314861ea-2c07-4a76-9037-7948f6843992

Similar Items